Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Papillary Serous Endometrial Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00005840
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

Who this might be right for
Endometrial Clear Cell AdenocarcinomaEndometrial Serous AdenocarcinomaStage III Uterine Corpus Cancer+1 more
Gynecologic Oncology Group 35
Testing effectiveness (Phase 2)Looking for participantsNCT06369155
What this trial is testing

Azenosertib in Uterine Serous Carcinoma: Biomarker Study

Who this might be right for
Uterine Serous CarcinomaUterine CarcinomaUterine Cancer
Joyce Liu, MD 25
Very early researchActive Not RecruitingNCT04494113
What this trial is testing

Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy

Who this might be right for
Endometrial Serous Adenocarcinoma
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Ended earlyNCT00231829
What this trial is testing

A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers

Who this might be right for
Uterine Cancer
Mark H. Einstein 23
Large-scale testing (Phase 3)Study completedNCT01672892
What this trial is testing

Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer

Who this might be right for
Cervical CancerEndometrial CancerGastrointestinal Complications+4 more
Radiation Therapy Oncology Group 289
Large-scale testing (Phase 3)Study completedNCT03285802
What this trial is testing

Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation

Who this might be right for
Uterine Cancer
Greater Baltimore Medical Center 1
Large-scale testing (Phase 3)UnknownNCT00807768
What this trial is testing

Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer

Who this might be right for
Endometrial Clear Cell AdenocarcinomaEndometrial Serous AdenocarcinomaFatigue+4 more
Gynecologic Oncology Group 601
Testing effectiveness (Phase 2)Study completedNCT01210222
What this trial is testing

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+4 more
Gynecologic Oncology Group 35
Testing effectiveness (Phase 2)Looking for participantsNCT02491099
What this trial is testing

A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma

Who this might be right for
HER2/Neu+ Uterine Serous Carcinoma
Yale University 50
Not applicableStudy completedNCT01267357
What this trial is testing

P16 Staining as Prognostic Biomarker in Serous Papillary Endometrial Cancer

Who this might be right for
Serous Papillary Endometrial Cancer
Rambam Health Care Campus 62
Testing effectiveness (Phase 2)Study completedNCT00072176
What this trial is testing

Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous Cell CarcinomaEndometrial Clear Cell Carcinoma+7 more
National Cancer Institute (NCI) 62
Not applicableStudy completedNCT01344837
What this trial is testing

Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

Who this might be right for
Endometrial Serous AdenocarcinomaStage I Uterine Corpus CancerStage II Uterine Corpus Cancer+2 more
Gynecologic Oncology Group 360
Testing effectiveness (Phase 2)Study completedNCT01132820
What this trial is testing

Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+2 more
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Study completedNCT00888173
What this trial is testing

Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Adenocarcinoma+6 more
Gynecologic Oncology Group 45
Testing effectiveness (Phase 2)WithdrawnNCT03836157
What this trial is testing

Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial AdenocarcinomaEndometrial Serous Adenocarcinoma+1 more
University of Oklahoma
Testing effectiveness (Phase 2)Study completedNCT00515073
What this trial is testing

Papillary Serous Carcinoma of the Endometrium

Who this might be right for
Endometrial Cancer
M.D. Anderson Cancer Center 30
Early research (Phase 1)Study completedNCT01935973
What this trial is testing

Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Cell Adenocarcinoma+3 more
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)UnknownNCT00003560
What this trial is testing

Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Endometrial CancerFallopian Tube CancerOvarian Cancer+1 more
Herbert Irving Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00022620
What this trial is testing

Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Study completedNCT01935934
What this trial is testing

Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Endometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Cell Adenocarcinoma+7 more
National Cancer Institute (NCI) 102
Next Page